Levonorgestrel

CAS 797-63-7 14 current records 6 historicalSmall Molecule

Who holds supplier records for Levonorgestrel? 14 organisations hold a current record for Levonorgestrel: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability (8 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (4), China (3), Taiwan (2), Germany (1) and 3 other countries (3); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Levonorgestrel: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/levonorgestrel

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Levonorgestrel expires 7 Sept 2040. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Levonorgestrel. Country is the organisation's recorded country, not necessarily the manufacturing site.

India4China3Taiwan2Germany1Hungary1Italy1Malta1Country not recorded for 1
Need Levonorgestrel sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Levonorgestrel, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
GEDEON RICHTER PLC. Budapest XHU
CEP 2026-245 - Rev 00
Levonorgestrel, Micronised - Dorog site
Jun 2026Inspected Jun 2026
Hungary
INDUSTRIALE CHIMICA S.R.L. SaronnoIT
CEP 2025-476 - Rev 00
Levonorgestrel, Process 2
Dec 2025Inspected Oct 2025
Italy
HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou CityCN
CEP 2022-199 - Rev 01
Levonorgestrel, Non-micronised and micronised
Nov 2025Inspected Nov 2023
Germany
QINHUANGDAO ZIZHU PHARMACEUTICAL CO., LTD. Qinhuangdao CityCN
CEP 2022-225 - Rev 02
Levonorgestrel, Micronised, Process II
Oct 2025—
LUPIN LIMITED MumbaiIN
CEP 2012-349 - Rev 01
Levonorgestrel
Sept 2024—
STERLING CHEMICAL MALTA LTD. BirzebbugiaMT
R0-CEP 2021-255 - Rev 01
Levonorgestrel, Micronised, code 200318
Jun 2023—
GEDEON RICHTER PLC. BudapestHU
R1-CEP 1999-141 - Rev 04
Levonorgestrel
Dec 2021—
BAYER AG LeverkusenDE
R1-CEP 2000-101 - Rev 03
Levonorgestrel, Micro 20
Mar 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Levonorgestrel are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • INDO PHYTO CHEMICALS PRIVATE LTD
    Inactive DMF 26064 · filed May 2012
  • BAYER PHARMA AG
    Inactive DMF 18403 · filed Jun 2005
  • HOECHST MARION ROUSSEL SA
    Inactive DMF 14288 · filed Jul 1999
  • HUBEI PHARMACEUTICAL FACTORY
    Inactive DMF 12994 · filed May 1998
  • YANGZHOU PHARMACEUTICAL FACTORY
    Inactive DMF 12934 · filed Mar 1998
  • Finland · Inactive DMF 10218 · filed May 1993

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (18 listed products contain Levonorgestrel). The latest listed patent expires 7 Sept 2040. The latest listed exclusivity ended 29 Jun 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Levonorgestrel is a synthetic progestogen used in various hormonal contraceptives, including emergency contraceptive pills. It works by preventing ovulation and fertilization of an egg.

Chemical identity

IUPAC name
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
Canonical SMILES
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
InChIKey
WWYNJERNGUHSAO-XUDSTZEESA-N
Synonyms
Plan B API, afirmelle component levonorgestrel, alesse component levonorgestrel, altavera component levonorgestrel, aviane component levonorgestrel, bay86-5028, climara pro component levonorgestrel, elifemme component levonorgestrel, enpresse component levonorgestrel, fallback solo, implant with levonorgestrel, introvale component levonorgestrel

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Progestin; Progestin-containing Intrauterine Device; Progestin-containing Intrauterine System
Physiologic effect
Inhibit Ovum Fertilization
Chemical structure
Progesterone Congeners

Therapeutic areas

ContraceptionHormonal TherapyEmergency Contraception

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Levonorgestrel?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Levonorgestrel: Bayer AG (Germany), Gedeon Richter (Hungary), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (China), INDUSTRIALE CHIMICA SRL (Italy), Lupin Limited (India), QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD (China), STERLING CHEMICAL MALTA LTD (Malta) and Cipla Limited (India), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Levonorgestrel Drug Master Files are active?

Bayer AG (DMF 4178), Gedeon Richter (DMF 8806), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (DMF 33000), INDUSTRIALE CHIMICA SRL (DMF 16696), Lupin Limited (DMF 22508), QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD (DMF 27692), STERLING CHEMICAL MALTA LTD (DMF 28502) and Cipla Limited (DMF 21547) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Levonorgestrel records mean?

6 organisations have only inactive Type II DMFs for Levonorgestrel. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Levonorgestrel have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Levonorgestrel on the EDQM register, including GEDEON RICHTER PLC. Budapest X (HU), INDUSTRIALE CHIMICA S.R.L. Saronno (IT), HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou City (CN), QINHUANGDAO ZIZHU PHARMACEUTICAL CO., LTD. Qinhuangdao City (CN), LUPIN LIMITED Mumbai (IN) and STERLING CHEMICAL MALTA LTD. Birzebbugia (MT) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Levonorgestrel?

Yes. The latest patent listed for an approved US product containing Levonorgestrel expires 7 Sept 2040, across 18 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Levonorgestrel supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Levonorgestrel?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.